In TAC-induced cardiac hypertrophy in 5-week old Sprague Dawley rats, tryptase inhibition with nafamostat mesilate (5 mg/kg/day) reduced the ratio of LV weight to tibia length (TL) and plasma chymase levels. This evidence concerns the gene CMA1 and cardiac hypertrophy.